In light of these results, we propose that Nr-CWS, as an immunotherapeutic agent for HR-HPV infection and CIN, plays an efficient part in immune enhancement and treatment, through upregulating T cell subsets and inhibiting PD-1/PD-L1 signal pathway. The gene discussed is CD274; the disease is cervical squamous intraepithelial neoplasia.